Related Experiment Video
Updated: Mar 8, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.7K
Stroke Prevention: Not all Antihypertensive Drugs are Created Equal
Franz H Messerli1, Simbo M Chiadika2
1St Luke's-Roosevelt Hospital, New York, US, Fmesserli@aol.com.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|January 20, 2017
Summary
Angiotensin receptor blockers offer superior stroke prevention compared to other antihypertensives by targeting the AT2-receptor. This dual mechanism provides enhanced cerebroprotection for hypertensive patients.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Hypertension management aims to reduce cardiovascular events.
- Beta-blockers lower blood pressure but do not consistently reduce stroke risk.
- Calcium channel blockers show superiority over ACE inhibitors in stroke prevention.
Purpose of the Study:
- To investigate the cerebroprotective effects of different antihypertensive drug classes.
- To explore the role of AT2-receptor stimulation in stroke prevention.
- To highlight the dual mechanism of angiotensin receptor blockers.
Main Methods:
- Review of clinical trials and meta-analyses on antihypertensive agents.
- Comparison of stroke risk reduction across various drug classes.
- Analysis of drug mechanisms, including AT1 and AT2 receptor interactions.
Main Results:
- Calcium channel blockers demonstrated greater efficacy in preventing strokes than ACE inhibitors.
- Antihypertensive agents stimulating the AT2-receptor (e.g., calcium antagonists, ARBs) appear more cerebroprotective.
- Angiotensin receptor blockers (ARBs) exhibit a dual mechanism (AT1 inhibition, AT2 stimulation) linked to excellent cerebroprotection.
Conclusions:
- ARBs offer a promising therapeutic strategy for stroke prevention in hypertensive individuals.
- Targeting the AT2-receptor may be a key factor in achieving superior cerebroprotection.
- The dual action of ARBs provides a unique advantage in managing stroke risk beyond blood pressure reduction.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
432
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.7K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.7K
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
799
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
799
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K